Research location

Zawadzkie

Poland

Published trials29

Site observations29

Linked trials published29

Page1 / 1

Research activity in Zawadzkie

Poland

CureCurrent currently publishes aggregate city-level research activity for this location: 29 trials and 29 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Zawadzkie

29 linked trials · page 1 of 1

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaNCT07323654 · 2026-01-28 · 1 site observation

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsNCT06052267 · 2023-08-30 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDNCT04320342 · 2022-04-27 · 1 site observation

Dose-range Finding Efficacy and Safety Study for QBW251 in COPD PatientsNCT04072887 · 2019-09-12 · 1 site observation

Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and AsthmaNCT03681093 · 2019-03-26 · 1 site observation

A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT03474081 · 2018-03-29 · 1 site observation

Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With AsthmaNCT03248128 · 2017-10-20 · 1 site observation

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With AsthmaNCT02554786 · 2015-12-29 · 1 site observation

Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With AsthmaNCT02571777 · 2015-12-08 · 1 site observation

Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.NCT02296138 · 2015-01-13 · 1 site observation

Efficacy Of Bacterial Lysate In Asthmatic ChildrenNCT02541331 · 2014-07-01 · 1 site observation

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent AsthmaNCT02040766 · 2013-12-01 · 1 site observation

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of AsthmaNCT01720069 · 2012-10-01 · 1 site observation

A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With AsthmaNCT01641692 · 2012-05-01 · 1 site observation

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in ChildrenNCT01573767 · 2012-04-01 · 1 site observation

Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of AsthmaNCT01472757 · 2011-10-01 · 1 site observation

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)NCT01329029 · 2011-05-01 · 1 site observation

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate CombinationNCT01321463 · 2011-05-01 · 1 site observation

Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent AsthmaticsNCT01165138 · 2010-08-20 · 1 site observation

Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT01069289 · 2010-01-01 · 1 site observation

Dose Ranging Efficacy And Safety With Mepolizumab in Severe AsthmaNCT01000506 · 2009-11-01 · 1 site observation

A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With TiotropiumNCT00949975 · 2009-07-01 · 1 site observation

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.NCT00603382 · 2007-12-01 · 1 site observation

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.NCT00496470 · 2007-05-01 · 1 site observation

A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With AsthmaNCT00384189 · 2006-09-01 · 1 site observation

A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)NCT00363896 · 2006-07-01 · 1 site observation

Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)NCT00163449 · 2005-11-01 · 1 site observation

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsNCT00206154 · 2005-04-01 · 1 site observation

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)NCT00163462 · 2004-10-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.